Quick10K

⚲

Engility

Filings

10-Q	2018-09-28	Filed 2018-10-31
10-Q	2018-06-29	Filed 2018-08-01
10-Q	2018-03-30	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-03-02
10-Q	2017-09-29	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-03-09
10-Q	2016-09-30	Filed 2016-11-01
10-Q	2016-07-01	Filed 2016-08-01
10-Q	2016-04-01	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-03-08
10-Q	2015-06-30	Filed 2015-08-06
10-Q	2015-03-31	Filed 2015-05-12
10-Q	2014-12-31	Filed 2015-11-06
10-K	2014-12-31	Filed 2015-03-04
10-Q	2014-09-30	Filed 2014-10-28
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-12
10-K	2013-12-31	Filed 2014-03-13
10-Q	2013-09-27	Filed 2013-11-12
10-Q	2013-06-28	Filed 2013-08-12
10-Q	2013-03-29	Filed 2013-05-13
10-K	2012-12-31	Filed 2013-03-21
10-Q	2012-09-28	Filed 2012-11-13
10-Q	2012-06-29	Filed 2012-08-13

Reports

8-K	2019-01-14
8-K	2019-01-11
8-K	2018-12-31
8-K	2018-11-09
8-K	2018-10-31
8-K	2018-09-10
8-K	2018-09-10
8-K	2018-09-09
8-K	2018-08-01
8-K	2018-05-24
8-K	2018-05-02
8-K	2018-03-21
8-K	2018-02-28
8-K	2018-01-05

Engility Financials

EGL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Tucson Electric Power (TEP)	1,446	49%	31.0	0%	5,303	1,737	1,444	706	0	97	3,000
Endocyte (ECYT)	1,444	0%	-33.3	-12%	355	8	0	0	-41	-41	1,377
Invesco DB Commodity Index Tracking Fund (DBC)	1,422		14.2	7%	1,438	33	0	0	100	100	1,422
Sonic (SONC)	1,407	0%	12.1	13%	531	820	424	0	71	172	2,084
Ping Identity (PING)	1,400	77%	422.8	-0%	848	168	62	48	-1	3	1,394
MiMedx Group (MDXG)	1,394	88%	25.0	20%	179	36	303	267	35	54	1,357
Toga (TOGL)	1,380	26%	-105.4	-67%	20	9	11	3	-13	-13	1,367
Ruhnn Holding (RUHN)	1,367			0%	689	781	0	0	0	0	1,263
Mitel Networks (MITL)	1,350	58%	10.5	-1%	1,455	1,053	1,304	752	-14	171	1,791
Turning Point Therapeutics (TPTX)	1,323		-17.6	-12%	436	16	0	0	-51	-51	900
Covetrus (CVET)	1,318	20%	-2.8	-28%	3,328	1,989	2,027	397	-916	-858	2,438
Engility (EGL)	1,300	0%	14.1	-2%	1,965	1,257	1,901	0	-34	156	2,197
web.com (WEB)	1,285	67%	12.5	3%	1,500	1,199	751	507	50	152	1,899
SuperValu (SVU)	1,258	8%	15.7	-0%	4,056	3,620	14,620	1,194	-19	168	2,645
K2M Group Holdings (KTWO)	1,193	64%	-36.8	-11%	422	192	281	181	-47	-31	1,137
KMG Chemicals (KMG)	1,185	42%	12.6	8%	818	402	466	198	65	117	1,473
Capella Education (CPLA)	1,175	0%	15.7	9%	287	59	443	0	27	67	1,057
State Bank Financial (STBZ)	1,168		8.1	1%	4,924	4,260	0	0	59	119	960
Health Catalyst (HCAT)	1,154	0%	-41.8	-10%	320	113	76	0	-32	-28	1,150
Healthcare Trust (HCT)	1,116	29%	20.4	-2%	2,331	1,194	372	108	-50	51	1,044


Balance Sheet ($MM)	2012-06-29	2012-09-28	2012-12-31	2013-03-29	2013-06-28	2013-09-27	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-12-31	2016-04-01	2016-07-01	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-29	2017-12-31	2018-03-30	2018-06-29	2018-09-28
Cash	10	19	27	39	47	24	29	11	23	19	7	32	37	30	39	33	61	48	25	31	52	42	22	40	42
Accounts Receivable																							101	84	76
Inventory
PP&E	12	12	42	11	10	11	45	20	20	18	49	34	37	76	44	51	49	76	46	44	44	78	42	45	49
Assets	1,439	1,034	1,027	1,049	1,028	959	930	1,179	1,155	1,136	1,123	2,633	2,615	2,275	2,247	2,230	2,234	2,199	2,152	2,133	2,130	2,026	2,011	2,004	1,965
Accounts Payable	43	31	21	27	28	23	28	46	35	32	49	65	67	54	59	62	57	44	52	54	50	53	52	47	45
Long-Term Debt		335	335	335	322	230	198	380	360	322	293	1,190	1,184	1,123	1,093	1,074	1,140	1,124	1,091	1,064	1,037	1,013	993	968	938
Liabilities	365	710	639	644	608	524	487	727	687	653	646	1,711	1,677	1,569	1,544	1,521	1,538	1,494	1,439	1,412	1,397	1,350	1,327	1,303	1,257
Stockholders' Equity	1,062																						674	691	699


Income Statement ($MM)	2012-06-29	2012-09-28	2012-12-31	2013-03-29	2013-06-28	2013-09-27	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-12-31	2016-04-01	2016-07-01	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-29	2017-12-31	2018-03-30	2018-06-29	2018-09-28
Revenue	433	409	-0	362	377	339	329	339	364	345	320	403	575	537	523	535	512	506	485	495	487	465	477	489	471
Cost of Revenue	366	359	327	315	328	289	282
Gross Profit	67	50	-327	46	49	50	47
R&D
SG&A	36	37	42	16	20	20	29	27	36	25	34	59	51	44	47	43	39	36	36	38	33	35	37	40	44
Tax	13	1	-20	9	17	9	5	7	8	9	7	-6	0	-52	-1	2	1	-5	5	6	6	64	2	5	5
Net Income	17	-419	41	15	447	14	11	10	12	14	2	-13	15	-239	-2	4	-15	7	8	9	11	-60	7	14	5


Cash Flow ($MM)	2012-06-29	2012-09-28	2012-12-31	2013-03-29	2013-06-28	2013-09-27	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-12-31	2016-04-01	2016-07-01	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-29	2017-12-31	2018-03-30	2018-06-29	2018-09-28
Cash Operating			-12	13	22	75	41	12	32	37	22	-48		-12	30		32	10	14	37	54	19	6		42
Cash Investing			-0	-0	-1	-1	-2	-208	-1	-1	-3	25		-7	-4		-8	-4	24	-1	-4	-4	-3		-8
Cash Financing			20	-1	-13	-97	-35	178	-19	-40	-31	48		-27	-16		3	-17	-5	-30	-29	-25	-23		-32